Fingerprint
Dive into the research topics of 'A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease
Abdullah Kutlar, Marvin E. Reid, Adlette Inati, Ali T. Taher, Miguel R. Abboud, Amal El-Beshlawy, George R. Buchanan, Hedy Smith, Kenneth I. Ataga, Susan P. Perrine, Richard G. Ghalie
Research output: Contribution to journal › Article › peer-review
29
Scopus
citations